Product Information
ACETAMINOPHEN-COD #3 TABLET is a generic product labeled by Strides Pharma Inc., priced at $0.2556 per EA under NDC 64380044601. Its NADAC has been published 120 times since Jun 19, 2024.
FDA first approved this application on Sep 30, 1988. Its Orange Book therapeutic-equivalence code is AA.
Strength
300; 30 mg/1; mg/1
Manufacturer
Strides Pharma Inc.NDC
64380044601
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ACETAMINOPHEN; CODEINE PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA089805FDA Approved
9/30/1988
TE Code
AA
On Market Since
5/20/2024
Pharmacological Classes
Price Statistics
The NADAC for ACETAMINOPHEN-COD #3 TABLET has been published 120 times since Jun 19, 2024, and over the history we have for it it has declined 7.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2556 per EA |
|---|---|
| All-time high | $0.2764 (Jul 10, 2024) |
| All-time low | $0.2090 (Apr 22, 2026) |
| 52-week high | $0.2764 |
| 52-week low | $0.2090 |
| Median price | $0.2505 |
| Average price | $0.2465 |
| Largest weekly change | -19.4% (Nov 20, 2024) |
| Weeks tracked | 120 |
| Tracking since | Jun 19, 2024 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 16% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Strides Pharma Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Acetaminophen and Codeine Phosphate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ACETAMINOPHEN-COD #3 TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ACETAMINOPHEN-COD #3 TABLET, manufactured by Strides Pharma Inc., is $0.2556 per EA (NDC 64380044601), effective Sep 30, 2026.
How has the price of ACETAMINOPHEN-COD #3 TABLET changed over time?
Over the history we have for it, the NADAC for ACETAMINOPHEN-COD #3 TABLET has declined 7.5%. It has been tracked across 120 weekly CMS publications since Jun 19, 2024.
What are the highest and lowest recorded NADAC prices for ACETAMINOPHEN-COD #3 TABLET?
Since Jun 19, 2024, the NADAC for ACETAMINOPHEN-COD #3 TABLET has ranged from a low of $0.2090 (Apr 22, 2026) to a high of $0.2764 (Jul 10, 2024), with a median of $0.2505 per EA.
Are there cheaper alternatives to ACETAMINOPHEN-COD #3 TABLET?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ACETAMINOPHEN-COD #3 TABLET, is $0.2144 per EA — about 16% below ACETAMINOPHEN-COD #3 TABLET.
Who manufactures ACETAMINOPHEN-COD #3 TABLET?
ACETAMINOPHEN-COD #3 TABLET (NDC 64380044601) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.